CD40 ligand deficiency in Latin America: clinical, immunological, and genetic characteristics (2022)
Source: Journal of Clinical Immunology. Unidade: ICB
Subjects: IMUNOGLOBULINAS, ESTUDOS DE COORTES, ESTUDOS RETROSPECTIVOS, IMUNOLOGIA, IMUNODEFICIÊNCIA DE VARIÁVEL COMUM, REGISTROS MÉDICOS, IMUNOGENÉTICA, MUTAÇÃO GENÉTICA
ABNT
FRANÇA, Tábata Takahashi; BARREIROS, Lucila Akune; SALGADO, Ranieri Coelho; et al. CD40 ligand deficiency in Latin America: clinical, immunological, and genetic characteristics. Journal of Clinical Immunology, New York, p. 1-13, 2022. Disponível em: < https://doi.org/10.1007/s10875-021-01182-5 > DOI: 10.1007/s10875-021-01182-5.APA
França, T. T., Barreiros, L. A., Salgado, R. C., Napoleão, S. M. da S., Gomes, L. N., Ferreira, J. F. S., et al. (2022). CD40 ligand deficiency in Latin America: clinical, immunological, and genetic characteristics. Journal of Clinical Immunology, 1-13. doi:10.1007/s10875-021-01182-5NLM
França TT, Barreiros LA, Salgado RC, Napoleão SM da S, Gomes LN, Ferreira JFS, Prando C, Weber CW, Gesu RSWD, Condino Neto A. CD40 ligand deficiency in Latin America: clinical, immunological, and genetic characteristics [Internet]. Journal of Clinical Immunology. 2022 ; 1-13.Available from: https://doi.org/10.1007/s10875-021-01182-5Vancouver
França TT, Barreiros LA, Salgado RC, Napoleão SM da S, Gomes LN, Ferreira JFS, Prando C, Weber CW, Gesu RSWD, Condino Neto A. CD40 ligand deficiency in Latin America: clinical, immunological, and genetic characteristics [Internet]. Journal of Clinical Immunology. 2022 ; 1-13.Available from: https://doi.org/10.1007/s10875-021-01182-5